Bell G - Search Results

1

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.

Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, Fernandez-Ortiz A, Schoors D, Radke P, Belli G, Brennan D, Bell G, Krucoff M; PROTECTION AMI Investigators. Lincoff AM, et al. Among authors: bell g. Eur Heart J. 2014 Oct 1;35(37):2516-23. doi: 10.1093/eurheartj/ehu177. Epub 2014 May 5. Eur Heart J. 2014. PMID: 24796339 Clinical Trial.

2

Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT. Bagai A, et al. Among authors: bell g. Am Heart J. 2014 Oct;168(4):503-511.e2. doi: 10.1016/j.ahj.2014.06.008. Epub 2014 Jun 9. Am Heart J. 2014. PMID: 25262260 Clinical Trial.

3

Utility of CMR Markers of Myocardial Injury in Predicting LV Functional Recovery: Results from PROTECTION AMI CMR Sub-study.

Grover S, Bell G, Lincoff M, Jeorg L, Madsen PL, Huang S, Leow S, Figtree G, Chakrabarty A, Leong DP, Woodman RJ, Selvanayagam JB. Grover S, et al. Among authors: bell g. Heart Lung Circ. 2015 Sep;24(9):891-7. doi: 10.1016/j.hlc.2015.03.001. Epub 2015 Mar 24. Heart Lung Circ. 2015. PMID: 25846255 Clinical Trial.

4

A single-center, randomized, double-blind, active, and placebo-controlled study of KAI-1678, a novel PKC-epsilon inhibitor, in the treatment of acute postoperative orthopedic pain.

Moodie JE, Bisley EJ, Huang S, Pickthorn K, Bell G. Moodie JE, et al. Among authors: bell g. Pain Med. 2013 Jun;14(6):916-24. doi: 10.1111/pme.12088. Epub 2013 Apr 8. Pain Med. 2013. PMID: 23565709 Clinical Trial.

5

The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.

Cousins MJ, Pickthorn K, Huang S, Critchley L, Bell G. Cousins MJ, et al. Among authors: bell g. Pain Med. 2013 Apr;14(4):533-40. doi: 10.1111/pme.12058. Epub 2013 Feb 25. Pain Med. 2013. PMID: 23438341 Clinical Trial.

6

Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.

Mahler DA, Huang S, Tabrizi M, Bell GM. Mahler DA, et al. Chest. 2004 Sep;126(3):926-34. doi: 10.1378/chest.126.3.926. Chest. 2004. PMID: 15364775 Clinical Trial.

7

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients.

Bell G, Huang S, Martin KJ, Block GA. Bell G, et al. Curr Med Res Opin. 2015 May;31(5):943-52. doi: 10.1185/03007995.2015.1031731. Curr Med Res Opin. 2015. PMID: 25786369 Clinical Trial.

8

AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients.

Martin KJ, Pickthorn K, Huang S, Block GA, Vick A, Mount PF, Power DA, Bell G. Martin KJ, et al. Among authors: bell g. Kidney Int. 2014 Jan;85(1):191-7. doi: 10.1038/ki.2013.289. Epub 2013 Jul 31. Kidney Int. 2014. PMID: 23903371 Free article. Clinical Trial.

9

Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients.

Walter S, Baruch A, Dong J, Tomlinson JE, Alexander ST, Janes J, Hunter T, Yin Q, Maclean D, Bell G, Mendel DB, Johnson RM, Karim F. Walter S, et al. Among authors: bell g. J Pharmacol Exp Ther. 2013 Aug;346(2):229-40. doi: 10.1124/jpet.113.204834. Epub 2013 May 14. J Pharmacol Exp Ther. 2013. PMID: 23674604

10

Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects.

Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, Peacock M. Martin KJ, et al. Among authors: bell g. Nephrol Dial Transplant. 2014 Feb;29(2):385-92. doi: 10.1093/ndt/gft417. Epub 2013 Nov 13. Nephrol Dial Transplant. 2014. PMID: 24235081 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,048 results

Search Page